The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Bothwell Ian T since 2008.
This trader's CIK number is 1207638.
At the time of last reporting, Bothwell Ian T was the Chief Financial Officer of Organicell Regenerative Medicine, Inc.. (stock ticker symbol BPSR).
Also see all insider trading activities at Organicell Regenerative Medicine, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | BPSR | 0 | $0 | 1,156,274 | $228,526 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2008 | RVEP | 8,812 | $124,998 | 0 | $0 | 0 | $0 |
1. Organicell Regenerative Medicine, Inc. (BPSR)
2. Rio Vista Energy Partners Lp (RVEP)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-06-17 | BPSR | Sale | 50,000 | .14 | 6,900 |
| 2021-06-14 | BPSR | Sale | 50,000 | .14 | 7,000 |
| 2021-06-15 | BPSR | Sale | 50,000 | .16 | 8,000 |
| 2021-06-16 | BPSR | Sale | 90,000 | .15 | 13,860 |
| 2021-06-04 | BPSR | Sale | 100,000 | .14 | 13,900 |
| 2021-06-07 | BPSR | Sale | 100,000 | .12 | 12,400 |
| 2021-06-08 | BPSR | Sale | 100,000 | .14 | 14,299 |
| 2021-06-02 | BPSR | Sale | 90,000 | .17 | 14,850 |
| 2021-06-01 | BPSR | Sale | 50,000 | .19 | 9,600 |
| 2021-05-18 | BPSR | Sale | 50,000 | .22 | 11,000 |
| 2021-05-19 | BPSR | Sale | 75,000 | .22 | 16,500 |
| 2021-05-20 | BPSR | Sale | 76,274 | .19 | 14,492 |
| 2021-05-17 | BPSR | Sale | 75,000 | .20 | 15,225 |
| 2021-05-13 | BPSR | Sale | 50,000 | .27 | 13,500 |
| 2021-05-14 | BPSR | Sale | 50,000 | .24 | 12,000 |
| 2021-04-29 | BPSR | Sale | 50,000 | .45 | 22,500 |
| 2021-04-30 | BPSR | Sale | 50,000 | .45 | 22,500 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2008-03-07 | RVEP | Buy | 8,812 | 14.19 | 124,998 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bothwell Ian T (Chief Financial Officer of Organicell Regenerative Medicine, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.